drugset / Trial / NCT02012335
Ketamine Use in Electroconvulsive Therapy
Withdrawn
Hospital de Clinicas de Porto Alegre
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether combination of ketamine plus electroconvulsive therapy improves depressive symptoms decreasing cognitive side effects.
Timeline
- Start
- 2014-01
- Primary completion
- 2016-01
- Completion
- 2016-01
Outcome
Outcome not reported
Stopped: “Methodologicals and logistics issues.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.05 mg/kg | — |